| 23.66 Data as of Jun 17 |  +0.15 / +0.64%Today’s Change | 18.37 Today|||52-Week Range 30.20 | -1.87% Year-to-Date |
| Previous close | 23.51 |
| Today’s open | 23.79 |
| Day’s range | 23.52 - 23.90 |
| Volume | 174,570 |
| Average volume (3 months) | 236,259 |
| Market cap | $384.6M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -3.36% |
| Earnings growth (next 5 years) | +90.00% |
| Revenue growth (last year) | +38.78% |
| P/E ratio | 29.9 |
| Price/Sales | 2.07 |
| Price/Book | 1.94 |
| Today’s change | Today’s % change | |
|---|---|---|
| IMMUImmunomedics Inc | +0.11 | +2.69% |
| ARAYAccuray Inc | +0.06 | +1.03% |
| TEARTearLab Corp | -0.03 | -0.26% |
| IVCInvacare Corp | -0.11 | -0.71% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $0.19 |
| Annual revenue (last year) | $153.5M |
| Annual profit (last year) | $11.0M |
| Net profit margin | 7.14% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael R. Davin |
Executive Vice President- Operations David Mackie |
Corporate headquarters Westford, Massachusetts |
.
